Literature DB >> 1913151

Terminal excitability of the corticostriatal pathway. I. Regulation by dopamine receptor stimulation.

M Garcia-Munoz1, S J Young, P M Groves.   

Abstract

Glutamatergic cortical and dopaminergic nigral afferents converge onto neurons of the neostriatum forming synapses in close proximity. Studies, mainly using pharmacological methods, suggest presynaptic interactions between these afferents. The influence of dopaminergic transmission on the cortical terminal fields in the striatum was assessed electrophysiologically using the terminal excitability method. Antidromic action potentials recorded from neurons in the prefrontal cortex were elicited by bipolar electrical stimulation (250 microns wire, 0.5 mm tip separation) of the cortical terminal field in the contralateral dorsomedial neostriatum. Threshold excitability was defined as the minimum current sufficient to elicit 95-100% antidromic response on non-collision trials. Under control conditions, the mean threshold current was 1.7 +/- 0.2 mA. Drugs were applied in a volume of 312 nl delivered over 5 min to the striatal stimulation site. Following local striatal administration of amphetamine (10 microM) or electrical stimulation of the nigrostriatal pathway (1-2 pulses, 1.5 mA/0.5 ms/1 Hz) an increase in striatal stimulating current was required in order to reinstate threshold levels of antidromic response. This decrease in the excitability of corticostriatal afferents could be reversed by local infusion of haloperidol (1 microM) or L-sulpiride (10 nM) and did not occur following depletion of dopamine stores with alpha-methylparatyrosine and reserpine. The possible participation of postsynaptic dopamine receptor stimulation was ruled out as these effects were still seen in animals with kainic acid induced lesions of the striatum. In addition, terminal excitability was not modified by the muscarinic agonist carbachol (10 microM). Striatal administration of apomorphine (10 microM) decreased terminal excitability similar to amphetamine. The specific D-2 agonist, quinpirole (10-20 microM) did not affect excitability. These results indicate that manipulations which have been shown to increase the release of endogenous dopamine decrease the excitability of prefrontal corticostriatal afferents by stimulation of presynaptic dopamine receptors which are insensitive to low doses of quinpirole but sensitive to L-sulpiride and apomorphine. The mechanisms underlying dopamine-induced changes in terminal excitability are likely to be similar to those which have been shown to alter conductance at postsynaptic sites.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1913151     DOI: 10.1016/0006-8993(91)90933-m

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  12 in total

1.  Modulation of dopamine D2 receptor expression by an NMDA receptor antagonist in rat brain.

Authors:  V D Nair; J E Savelli; R K Mishra
Journal:  J Mol Neurosci       Date:  1998-10       Impact factor: 3.444

2.  Endogenous dopamine increases extracellular concentrations of glutamate and GABA in striatum of the freely moving rat: involvement of D1 and D2 dopamine receptors.

Authors:  I Expósito; A Del Arco; G Segovia; F Mora
Journal:  Neurochem Res       Date:  1999-07       Impact factor: 3.996

Review 3.  Dopamine and synaptic plasticity in the neostriatum.

Authors:  G W Arbuthnott; C A Ingham; J R Wickens
Journal:  J Anat       Date:  2000-05       Impact factor: 2.610

4.  M1 muscarinic receptor stimulation decreases aspartate release in the rat neostriatum.

Authors:  I Expósito; B Sanz; F Mora
Journal:  Neurochem Res       Date:  1997-12       Impact factor: 3.996

5.  Striatal preproenkephalin gene expression is upregulated in acute but not chronic parkinsonian monkeys: implications for the contribution of the indirect striatopallidal circuit to parkinsonian symptomatology.

Authors:  J S Schneider; E Decamp; T Wade
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

6.  Functional anatomy: dynamic States in Basal Ganglia circuits.

Authors:  Marianela Garcia-Munoz; Luis Carrillo-Reid; Gordon W Arbuthnott
Journal:  Front Neuroanat       Date:  2010-11-23       Impact factor: 3.856

7.  Inhibitory action of dopamine involves a subthreshold Cs(+)-sensitive conductance in neostriatal neurons.

Authors:  M T Pacheco-Cano; J Bargas; S Hernández-López; D Tapia; E Galarraga
Journal:  Exp Brain Res       Date:  1996-07       Impact factor: 1.972

8.  Impact of dopamine-glutamate interactions on striatal neuronal nitric oxide synthase activity.

Authors:  Kristina E Hoque; Raksha P Indorkar; Stephen Sammut; Anthony R West
Journal:  Psychopharmacology (Berl)       Date:  2009-10-09       Impact factor: 4.530

9.  Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.

Authors:  A Svensson; A Carlsson; M L Carlsson
Journal:  J Neural Transm Gen Sect       Date:  1992

Review 10.  Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

Authors:  Kari A Johnson; David M Lovinger
Journal:  Front Cell Neurosci       Date:  2016-11-11       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.